Significance of interictal temporal lobe delta activity for localization of the primary epileptogenic region.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMID 9921879)

Published in Neurology on January 01, 1999

Authors

J D Geyer1, E Bilir, R E Faught, R Kuzniecky, F Gilliam

Author Affiliations

1: University of Alabama at Birmingham Epilepsy Center, Department of Neurology, The University of Alabama at Birmingham, 35294, USA.

Articles by these authors

Global assessment of nitrogen deposition effects on terrestrial plant diversity: a synthesis. Ecol Appl (2010) 4.61

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology (2004) 3.39

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology (2004) 3.34

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology (1999) 2.72

Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke (1998) 2.22

Congenital porencephaly: MR features and relationship to hippocampal sclerosis. AJNR Am J Neuroradiol (1998) 2.08

Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet (2001) 1.80

Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology (1999) 1.80

Bilateral parasagittal parietooccipital polymicrogyria and epilepsy. Ann Neurol (1997) 1.72

Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy. Ann Neurol (1997) 1.71

Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis. Neurology (1999) 1.48

Characterization of mutations in the gene doublecortin in patients with double cortex syndrome. Ann Neurol (1999) 1.47

Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia (1997) 1.41

Rotational vestibular epilepsy from the temporo-parieto-occipital junction. Neurology (2005) 1.40

Cortical abnormalities in epilepsy revealed by local EEG synchrony. Neuroimage (2007) 1.37

Bilateral porencephalic defect and bilateral perisylvian polymicrogyria. Brain Dev (1991) 1.37

Hippocampal sclerosis in temporal lobe epilepsy demonstrated by magnetic resonance imaging. Ann Neurol (1991) 1.34

Acute psychotic symptoms induced by topiramate. Seizure (1999) 1.34

Improved health care resource utilization following video-EEG-confirmed diagnosis of nonepileptic psychogenic seizures. Seizure (1998) 1.16

Weight loss associated with vagus nerve stimulation. Neurology (2002) 1.14

Familial perisylvian polymicrogyria: a new familial syndrome of cortical maldevelopment. Ann Neurol (2000) 1.13

Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology (2002) 1.12

Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology (1998) 1.11

Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res (2005) 1.09

Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study. Epilepsia (1999) 1.06

Subjective versus objective memory change after temporal lobe epilepsy surgery. Neurology (1999) 1.06

Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol (1995) 1.06

Epilepsy surgery outcome: comprehensive assessment in children. Neurology (1997) 1.05

Visual confrontation naming and hippocampal function: A neural network study using quantitative (1)H magnetic resonance spectroscopy. Brain (2000) 1.05

Adult myoclonic epilepsy: a distinct syndrome of idiopathic generalized epilepsy. Neurology (2000) 1.04

Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy. Neurology (2007) 1.02

Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain (2008) 0.99

Topiramate increases cerebral GABA in healthy humans. Neurology (1998) 0.99

Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy. Neurology (1997) 0.97

Multimodality MRI in mesial temporal sclerosis: relative sensitivity and specificity. Neurology (1997) 0.96

Predictive value of 1H MRSI for outcome in temporal lobectomy. Neurology (1999) 0.96

Frequency of epilepsy in patients with psychogenic seizures monitored by video-EEG. Neurology (2003) 0.95

Individual memory change after anterior temporal lobectomy: a base rate analysis using regression-based outcome methodology. Epilepsia (1998) 0.94

Quantitative MRI in temporal lobe epilepsy: evidence for fornix atrophy. Neurology (1999) 0.94

Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia (1994) 0.93

EEG spike detection with a Kohonen feature map. Ann Biomed Eng (2001) 0.93

Temporal lobe developmental malformations and epilepsy: dual pathology and bilateral hippocampal abnormalities. Neurology (1998) 0.92

Is the intracellular pH different from normal in the epileptic focus of patients with temporal lobe epilepsy? A 31P NMR study. Neurology (1996) 0.92

Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group. Seizure (2000) 0.92

Ambulatory EEG monitoring. J Clin Neurophysiol (1999) 0.91

Altered brain sodium channel transcript levels in human epilepsy. Brain Res Mol Brain Res (1996) 0.91

Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome. Brain (1988) 0.90

Bilateral hippocampal atrophy: consequences to verbal memory following temporal lobectomy. Neurology (2001) 0.89

Metabolic networks in epilepsy by MR spectroscopic imaging. Acta Neurol Scand (2012) 0.88

Postictal language assessment and lateralization of complex partial seizures. Ann Neurol (1991) 0.87

Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia (2001) 0.86

MRI extrahippocampal volumes and visual memory: correlations independent of MRI hippocampal volumes in temporal lobe epilepsy patients. J Int Neuropsychol Soc (1999) 0.86

Occipitoparietal epilepsy, hippocampal atrophy, and congenital developmental abnormalities. Epilepsia (2000) 0.86

Cognitive correlates of 1H MRSI-detected hippocampal abnormalities in temporal lobe epilepsy. Neurology (1999) 0.86

Temporal lobe developmental malformations and hippocampal sclerosis: epilepsy surgical outcome. Neurology (1999) 0.85

Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment. Epilepsia (1997) 0.84

Supplementary sensorimotor area epilepsy. Seizure localization, cortical propagation and subcortical activation pathways using ictal SPECT. Brain (1997) 0.84

Association of combined MRI, interictal EEG, and ictal EEG results with outcome and pathology after temporal lobectomy. Epilepsia (1997) 0.84

Rasmussen's encephalitis with concomitant cortical dysplasia: the role of GluR3. Epilepsia (1999) 0.84

Occipital lobe developmental malformations and epilepsy: clinical spectrum, treatment, and outcome. Epilepsia (1997) 0.83

Congenital porencephaly and hippocampal sclerosis. Clinical features and epileptic spectrum. Neurology (1997) 0.83

Verbal retention lateralizes patients with unilateral temporal lobe epilepsy and bilateral hippocampal atrophy. Epilepsia (2001) 0.83

Relationship between depression and intractability of seizures. Epilepsy Behav (2003) 0.83

Left vagus nerve stimulation suppresses experimentally induced pain. Neurology (2001) 0.83

Volumetric MRI of the limbic system: anatomic determinants. Neuroradiology (1998) 0.82

Effects of an activator on the masseter and anterior temporal muscle activities in Class II malocclusions. J Clin Pediatr Dent (1999) 0.82

Inorganic compounds have dual effect on recombinant protein production: influence of anions and cations on serine alkaline protease production. J Appl Microbiol (2004) 0.82

Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology (1993) 0.82

Parent- and patient-validated content for pediatric epilepsy quality-of-life assessment. Epilepsia (2000) 0.82

Abnormalities of cortical thickness in postictal psychosis. Epilepsy Behav (2011) 0.82

Qualitative MRI segmentation in mesial temporal sclerosis: clinical correlations. Epilepsia (1996) 0.81

Correlation of scalp EEG and 1H-MRS metabolic abnormalities in temporal lobe epilepsy. Epilepsia (2001) 0.81

Amygdala atrophy and seizure outcome after temporal lobe epilepsy surgery. Neurology (1998) 0.81

Relationships among hippocampal volumetry, proton magnetic resonance spectroscopy, and verbal memory in temporal lobe epilepsy. Epilepsia (2001) 0.81

Statistically driven identification of focal metabolic abnormalities in temporal lobe epilepsy with corrections for tissue heterogeneity using 1H spectroscopic imaging. Magn Reson Med (2000) 0.81

Myoclonus epilepsy and ragged-red fibres (MERRF). 2. Electrophysiological studies and comparison with other progressive myoclonus epilepsies. Brain (1989) 0.80

Benign occipital epilepsy: a family study. Epilepsia (1987) 0.80

Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures. Epilepsy Res (1995) 0.80

Intravenous prostacyclin in acute nonhemorrhagic stroke: a placebo-controlled double-blind trial. Stroke (1987) 0.79

Eclampsia, hippocampal sclerosis, and temporal lobe epilepsy: accident or association? Neurology (2004) 0.79